SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BioLase Technology, Inc. (BLTI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: upndn who wrote (656)8/27/2003 12:30:59 PM
From: upndn  Read Replies (1) of 706
 
Arnold did you get back in or do the YEEHAAS have you scared off? I bought yesterday and a little more today.
lol

Analyst update;

9:35AM Biolase Tech defended by Lazard (BLTIE) 11.17 +0.47: Lazard says that BLTI's stock has been weak due to concerns that the firm has been stigmatized by accounting issues (co failed to file its Q2 10-Q on time); firm believes that the rev recognition issue sounds worse than it is, given that the co's cash flows are not in question and the error that led to the need for a restatement was an error relating to an overly-conservative receivables policy; firm thinks the outstanding issues can be resolved easily and are likely to disappear in the near future, and believes BLTI shares should be bought now before the accounting uncertainty is cleared up. Maintains Buy rating and $17 target.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News